Literature DB >> 17331343

Intestinal efflux transport kinetics of green tea catechins in Caco-2 monolayer model.

K Y Chan1, Li Zhang, Zhong Zuo.   

Abstract

The bioavailability of green tea catechins (GTCs), including epigallocatechin gallate (EGCG), epigallocatechin (EGC), epicatechin gallate (ECG) and epicatechin (EC) is low in both animals and humans. The contribution of intestinal efflux to this low bioavailability has been suggested by previous studies. The objective of the present study was to investigate the kinetics of efflux transport of the four major GTCs in Caco-2 cell lines, to provide comparison on the efflux transport between each GTC. The basal-to-apical transport of each GTC at concentrations ranging from 15 to 265 microM was examined using the Caco-2 cell monolayer model. Transported amount of GTC was measured by high-performance liquid chromatography with electrochemical detection. Kinetic parameters, V(max), K(m) and V(max)/K(m) were determined and compared among the four studied GTCs. The extent of basal-to-apical transport was, in descending order, EC > EGC > ECG approximately EGCG. Kinetic studies indicated that active and saturable efflux transport of EC took place in Caco-2 cells, with a K(m) of 131 microM, a V(max) of 0.0249 nmol min cm(-2) and an intrinsic clearance (V(max)/K(m)) of 0.19 microL min cm(-2). No saturation could be observed for the efflux transport of EGC, ECG and EGCG even at concentrations up to about 200 microM, which may be due to their low affinity towards the transporters at the concentration range studied. In conclusion, the extent of efflux transport of GTCs in Caco-2 cells was, in descending order, EC > EGC > ECG approximately EGCG, which may reflect the order of elimination occurring in the intestine. The kinetic studies showed the importance of efflux transporters in basal-to-apical transport of EC and suggests their role in the limited oral bioavailability of EC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17331343     DOI: 10.1211/jpp.59.3.0009

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  4 in total

1.  Green Tea Polyphenols in drug discovery - a success or failure?

Authors:  Thomas J Smith
Journal:  Expert Opin Drug Discov       Date:  2011-06       Impact factor: 6.098

2.  Nanolipidic particles improve the bioavailability and alpha-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer's disease.

Authors:  Adam Smith; Brian Giunta; Paula C Bickford; Michael Fountain; Jun Tan; R Douglas Shytle
Journal:  Int J Pharm       Date:  2010-01-18       Impact factor: 5.875

3.  Physiological levels of tea catechins increase cellular lipid antioxidant activity of vitamin C and vitamin E in human intestinal caco-2 cells.

Authors:  Janjira Intra; Shiu-Ming Kuo
Journal:  Chem Biol Interact       Date:  2007-05-31       Impact factor: 5.192

Review 4.  Food-grade Encapsulation Systems for (-)-Epigallocatechin Gallate.

Authors:  Meng Shi; Yun-Long Shi; Xu-Min Li; Rui Yang; Zhuo-Yu Cai; Qing-Sheng Li; Shi-Cheng Ma; Jian-Hui Ye; Jian-Liang Lu; Yue-Rong Liang; Xin-Qiang Zheng
Journal:  Molecules       Date:  2018-02-17       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.